LY2979165

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Bipolar DisorderHealthy Volunteers

Phase 1

A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers

CompletedNCT01248052

Eli Lilly and CompanyBipolar Disorder

Start: 2010-11-30End: 2011-05-31Updated: 2011-06-27

A Study of LY2979165 in Healthy Subjects

CompletedNCT01383967

Eli Lilly and CompanyBipolar Disorder

Start: 2011-07-31End: 2012-06-30Updated: 2012-06-14

A Study of LY2979165 and LY2140023 in Healthy Volunteers

CompletedNCT01524237

Eli Lilly and CompanyHealthy Volunteers

Start: 2012-04-30End: 2013-07-31Target: 52Updated: 2013-08-02